Clinical Trials Directory

Trials / Completed

CompletedNCT04312048

the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion

the Effect of Vaginal Isosorbide Mononitrate Administration in Reducing Pain During Cooper Intrauterine Device Insertion in Nulliparous Women : a Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The aim of the study is to evaluate the efficacy of isosorbide mononitrate vaginal administration in reducing pain during copper IUD insertion in nulliparous women

Conditions

Interventions

TypeNameDescription
DRUGIsosorbide mononitrateone tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to copper IUD insertion
DRUGplaceboone tablet of placebo vaginally 3 hours prior to copper IUD insertion

Timeline

Start date
2020-04-15
Primary completion
2020-10-25
Completion
2020-11-30
First posted
2020-03-18
Last updated
2021-01-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04312048. Inclusion in this directory is not an endorsement.